Course Descriptions - 2007 OPA Annual Conference

FRIDAY, April 27

8:30 a.m. KEYNOTE SESSION
CE Credit: 0.1 CEU

Ten-City Challenge: The Asheville Project on Steroids
John Miall, Consultant
Former Director of Risk Management, Asheville, NC
Medication Therapy Management is no longer just theory. The Asheville Project and the 40+ replications nationwide by APhA Foundation are some of the most successful programs paying pharmacists for improving patient outcomes. We are fortunate to have John Miall, one of the visionaries behind the Asheville Project, keynote us on the Asheville Project and subsequent Ten-City Challenge program. He will have some preliminary data from the latter to share with attendees. His entertaining presentation style will show you that businesses have finally caught on to your importance in the health care system.
ACPE #129-000-07-019-L04

9:30 a.m.
CE Credit per Program: 0.1 CEU

Average Manufacturer Price: Impact in Community Pharmacy
Enrique Seoane-Vazquez, Ph.D.
Assistant Professor, College of Pharmacy & School of Public Health Scholar
The Ohio State University
The implications of the change from Average Wholesale Price (AWP) to Average Manufacturer Price (AMP) mandated by the Deficit Reduction Act of 2005 to estimate Medicaid drug ingredient reimbursement will be presented. The negative impact of the use of AMP in community pharmacy revenues and the overall effects to the retail pharmaceutical market will also be discussed.
ACPE #129-000-07-020-L04

Medicare/Medicaid & Pharmacy: Update 2007
Todd Stankewicz, R.Ph., MPH, MBA
Pharmacy Officer, Division of Medicare Operations
CMS Region V, Chicago, IL
Medicare Part D is now in its second year, and changes have occurred. This important session will bring you up to speed on changes in the program, as well as the challenges that occurred as it entered its second enrollment period. You will learn about electronic prescribing, MTMS, Medicaid pharmacy reimbursement, and implementation of the National Provider Identifier (NPI). This is a key session for any pharmacist who deals with Medicare and Medicaid patients.
ACPE #129-000-07-021-L04

Pharmacologic Management Strategies for Heart Failure
Garrie Haas, M.D.
Associate Professor of Clinical Medicine
Director, Clinical Trials Research Unit, OSU Medical Center
The role for neurohormonal antagonism and additional medical therapies for treating chronic heart failure due to LV systolic dysfunction will be reviewed, and a practical pharmacologic strategy for treatment will be presented. Treatment concepts will parallel the heart failure staging nomenclature as presented in the ACC/AHA Guidelines. The specific problem of diuretic resistance and cardio-renal syndrome will also be discussed.
ACPE #129-000-07-022-L01

From Poppy Field to Pharmacy Shelf: The Manufacture of Medicinal Narcotics
Ed Hesterlee, PharmD
Director, Professional & Trade Relations
Mallinckrodt Pharmaceuticals
There are various licenses and quotas used to regulate the importation and manufacture of natural narcotics in the United States. This program will teach pharmacists the natural narcotics production timeline and the agencies with oversight responsible for the process, as well as the "legitimate" world supply chain for the growth, importation, manufacture and distribution of natural narcotics.
ACPE #129-000-07-023-L04
Sponsor: Mallinckrodt Pharmaceuticals

10:35 a.m.
CE Credit per Program: 0.2 CEU

Pharmacotherapeutic Quandaries
Vince Mauro, PharmD
Professor of Clinical Pharmacy
University of Toledo College of Pharmacy
Using case study format, this session will apply pharmacotherapeutic and pharmacologic knowledge to avoid potential pharmacotherapeutic misadventures. The speaker will teach pharmacists to recognize clinically significant or unique drug interactions.
ACPE #129-000-07-024-L01

OTC and Self-Care Challenge
Andrea Wall, R.Ph., Assistant Dean for Student Affairs, University of Cincinnati College of Pharmacy and Kristin Casper, PharmD, Assistant Professor of Clinical Pharmacy, The Ohio State University
Would you like to update your knowledge of common self-care conditions and nonprescription products? Do you enjoy a little friendly competition? Come join us for OPA's first "OTC and Self-Care Challenge - Battle of the Colleges!" You will learn up-to-date information about nonprescription products along with the rationale for product choices, while cheering your team on to victory. Come join us for a highly interactive, fun-filled session that will enhance your OTC expertise!
ACPE #129-000-07-025-L01
Sponsor: Procter & Gamble

Deal or No Deal? Responding to Pharmacy's Hot Topics of 2007
Marc Sweeney, PharmD
Director & Chair, Pharmacy Practice Division
University of Findlay School of Pharmacy
Minute clinics, OTC morning-after pill, right to refuse, free drugs, vending machine dispensing, and pharmacist prescribing are all buzzwords of 2007 in the practice of pharmacy. Our speaker will educate pharmacists on what these issues are all about, so that they can respond appropriately when questioned by their patients or the news media. The impact of these issues and controversies, as well as advantages and disadvantages, will be outlined.
ACPE #129-000-07-026-L04

Avian Influenza and Federal Pandemic Preparedness
Joshua A. Mott, MA. EMT-P, PhD
Epidemiologist, Influenza Division
U.S. Centers for Disease Control and Prevention
It is difficult to predict when the next influenza pandemic will occur or how severe it will be. This session will review the epidemiology and transmission of seasonal and avian influenza in humans, as well as the current spread of avian influenza in humans and birds internationally. Our speaker will provide an update on recent pandemic preparedness activities with particular focus on anti-viral stockpiling, vaccine research and development, the expansion of laboratory capacity and development of rapid testing devices, and CDC preparedness activities.
ACPE #129-000-07-027-L01

2:00 p.m.
CE Credit per Program: 0.2 CEU

OhioResearch Forum 2007
Moderator: Curtis Black, R.Ph., Ph.D.
Professor of Clinical Pharmacy, University of Toledo College of Pharmacy
The Annual Ohio Research Forum showcases the research of Ohio pharmacists, college faculty, pharmacy residents and students. Topics include patient care, disease state management, proper drug therapy, pharmacoeconomic issues, technology in the profession, innovative pharmacy services, and many others. The Research Forum includes a platform session consisting of eight presentations, and a Poster Session immediately follows in the Exhibit Hall.
ACPE #129-000-07-028-L04
Sponsor: Procter & Gamble

"Yes We Can Order It - What is It?"
Denice R. Taylor, APRN, BC, CWOCN
CNP/manager Wound & Ostomy Department
Mount CarmelWest Hospital, Columbus, OH
Wound care has evolved from the use of traditional gauze dressings to treatment with a myriad of wound care products. This session will provide a review of the normal pathophysiology of the skin as a basis for understanding tissue trauma and the healing process of wounds. Our speaker will describe the different wound classification systems, explain how phases of healing and wound characteristics influence treatment and product selection, and provide examples of how different types of products are used.
ACPE #129-000-07-029-L01

Establishing a Collaborative Practice
David Meier, M.D., Staff Physician and Teresa Hoffmann, PharmD, CACP, Clinical Pharmacist
Blanchard Valley Medical Associates, Findlay, OH
In this unique presentation, pharmacists will learn a physician's perspective on collaborative practice, key concepts to consider when approaching a physician about starting a collaborative practice, and the types of patient populations that would best fit this model. Our pharmacist speaker will explain how to implement a collaborative practice and effectively use a consult agreement, how to overcome the barriers in establishing this type of practice, and the necessary components of a new collaborative practice.
ACPE #129-000-07-030-L04

Update on Parkinson's Disease
David Riley, M.D.
Department of Neurology
University Hospitals of Cleveland
Approximately one million Americans have Parkinson's disease, and the severity of symptoms varies tremendously from patient to patient. This session will review the pathophysiology and diagnosis of the disease, pharmacologic agents used as monotherapy and adjunctive therapy, and possible benefits of surgery. Drug dosage regimens, side effects, potential drug interaction concerns will be included.
ACPE #129-000-07-031-L01
Sponsor: Teva Neuroscience

SATURDAY, April 28
8:30 a.m.
CE Credit per Program: 0.2 CEU

Ohio Law Update 2007 (repeated at 10:30 a.m.)
Timothy Benedict, R.Ph., Assistant Executive Director and Danna Droz, R.Ph., J.D., Program Administrator for Prescription Drug Monitoring Program
OhioStateBoard of Pharmacy
This important session for all pharmacists will address recent changes in state and federal laws and regulations which impact the practice of pharmacy. Topics will include the implementation of the Ohio prescription monitoring program and physician assistant prescribing. You will have the opportunity to ask questions that apply specifically to your area of pharmacy practice. This program has been approved by the State Board of Pharmacy for 0.2 CEU of Ohio jurisprudence CE credit.
ACPE #129-000-07-032-L03

Medication Therapy Reviews
Marialice Bennett, R.Ph., FAPhA
Associate Clinical Professor, Pharmacy Practice and Administration
The Ohio State University
Conducting Medication Therapy Reviews (MTRs) is an essential part of every successful Medication Therapy Management (MTM) program. This presentation will describe the core elements of an MTR, describe techniques used to identify medication-related problems and how to resolve them, demonstrate a step-by-step process of conducting and documenting an MTR, as well as compare and contrast various documentation systems and innovative technologies for MTM services.
ACPE #129-000-07-033-L01

Health Care Associated Infections
Steven Martin, PharmD, BCPS, FCCM
Associate Professor of Clinical Pharmacy
University of Toledo College of Pharmacy
Health care associated infections differ from nosocomial infection, and this program will explain the difference. In addition, the risks for infection associated with interaction with the health care system, the current guidelines for management of specific health care associated infections, treatment differences from community- and nosocomial-acquired infections, and future implications on infectious disease of the changing health care delivery system will also be discussed.
ACPE #129-000-07-034-L01

Vaccine Update 2007
Donald Bennett, R.Ph, MBA
Quality Resource Manager
Pharmacy Systems, Inc. Dublin, OH
Vaccine preventable diseases are on the decline; however, we cannot takehigh immunization levels for granted. Pharmacists need to continue to protectadults and advocate for childhood immunizations. This program will provide background information on immunology; updates on influenza, pneumococcal, tetanus, hepatitis A & B, meningitis, and pertussis vaccines; and information on the new HPV and varicella-zoster vaccines. The role of health care providers in this important area will be detailed.
ACPE #129-000-07-035-L01

10:30 a.m.
CE Credit per Program: 0.2 CEU

OhioLaw Update 2007 (repeat of 8:30 a.m. program)

Cardiac Arrhythmias: A Review of Pathophysiology and Pharmacology
Jon E. Sprague, R.Ph., Ph.D.
Professor of Pharmacology and Dean
OhioNorthern University College of Pharmacy
Drug therapy of cardiac arrhythmias varies drastically from β-blockers to sodium channel blockers. The pharmacologic rationale for drug therapy will be reviewed based on drug mechanisms and the pathophysiology of cardiac arrhythmias. This program is intended to be a review of the fundamental pathophysiologic and pharmacologic mechanisms of drugs affecting cardiac arrhythmias.
ACPE #129-000-07-036-L01

Communication Tips for Successful MTMS
Phyllis Grauer, PharmD, CGP
Palliative Care Consulting Group
Communication skills are critical in providing successful Medication Therapy Management Services in your practice. Physicians need to understand what you are doing, and why it is not a threat to them. The patient must understand the importance of the service, and how it will benefit their health. Employers and payers need clear, concise descriptions of your activities for payment. This session will teach you successful communication skills including having a positive attitude, anticipating and preparing complete information, being assertive rather than aggressive, and listening.
ACPE #129-000-07-037-L04

Recent Advances in the Management of Type 1 Diabetes: Challenging the Vial/Syringe
Crystal Tubbs, PharmD
Assistant Director, Clinical Pharmacy Services
OhioState University Medical Center
This session will provide an overview of Type 1 diabetes�from diagnosis to inpatient and outpatient management. Our speaker will discuss the pathophysiology of diabetes mellitus, specifically insulin dependent diabetes mellitus; explain the pharmacology of currently available insulin products; and review supplies necessary for insulin dependent diabetes management. Current practice guidelines will be reviewed, in addition to recent advances in pharmacologic treatment options for this disease state.
ACPE #129-000-07-038-L01

2:30 p.m.
CE Credit per Program: 0.2 CEU

HIV Treatment Review and Update for Pharmacists
Michael Para, M.D.
Co-Principal Investigator of PennsylvaniaMidAtlantic AIDS Education and Training Center; Division of Infectious Diseases, OSU College of Medicine
This presentation will discuss the epidemiology of HIV/AIDS in our community and in the world. The speaker will describe the pathogenesis of the virus and the current treatment recommendations and the challenges of treatment.
ACPE #129-000-07-039-L02
Sponsor: Pennsylvania MidAtlantic AIDS Education and Training Center

Sterile Compounding
Paul W. Lofholm, PharmD, FACA
Clinical Professor of Pharmacy
Universityof California San Francisco
Compounding Pharmacists face a myriad of challenges today, especially in the quality assurance arena for sterile preparations. Our speaker will teach pharmacists how to design a sterile compounding facility, list minimum qualifications of persons compounding, detail a procedure for receiving and verifying bulk drugs from vendors, as well as the compounding steps to consider when preparing a sterile preparation. In addition, he will list quality control policies and procedures which are met prior to releasing a sterile compounded preparation and how to trouble shoot when problems arise. ACPE #129-000-07-040-L04
Sponsor: American College of Apothecaries

Addiction: Recognition and Recovery
Nick Kallis, R.Ph. and Michael Quigley, R.Ph.
Pharmacists Rehabilitation Organization, Inc.
The disease of addiction is treatable; recognizing the signs and symptoms is sometimes difficult. This program will include information on the disease, signs, symptoms, and treatment strategies. Pharmacists and students attending will learn the warning signs of impairment, consequences of addition, and how to get help for an impaired professional through the Pharmacists Rehabilitation Organization.
ACPE #129-000-07-041-L01
Sponsor: Pharmacists Rehabilitation Organization, Inc.

Medication Reconciliation
Deb Fearing, PharmD, Clinical Manager, Pharmacy Services and
Claire Rodehaver, RN, MS, OCN, CAN, BC, Director of Nursing * Oncology Services
Miami Valley Hospital, Dayton, OH
The pharmacist's role in medication reconciliation is becoming a vital part in managing patient disease states in the hospital and community settings alike. This session will provide an overview of the medication reconciliation process for hospital admission, transfer, and discharge, as well as its importance in clinical practice. In addition, this program will provide successful medication reconciliation strategies that can be implemented in various practice settings. Our speakers will define the role of the pharmacist within these processes and share first-hand experiences on its impact on patient care.
ACPE #129-000-07-042-L04

SUNDAY, April 29
8:30 a.m.
CE Credit per Program: 0.2 CEU

Treating Depression: A Strategic Approach
Randy A. Sansone, M.D. Professor, Psychiatry & Internal Medicine,
Wright State University Schoolof Medicine
Our speaker presents a pragmatic medication algorithm for the treatment of depression in the primary care setting. The program includes a review of antidepressant monotherapy strategies as well as the use of add-on medications, or augmentation strategies. Augmentation strategies to be discussed include the use of buspirone, anticonvulsants, atypical antipsychotics, and herbal products as well as more complicated strategies, which are primarily used in the psychiatric setting (e.g., lithium, T3, dual antidepressants).
ACPE #129-000-07-043-L01

Ohio Medicaid Update
TBA
ACS - Ohio Medicaid PBM
The Ohio Medicaid program has implemented numerous changes, including moving to Managed Care Organizations (MCOs), a new claims processor, and changes in federal reimbursement rules. This session will give you a chance to hear about the changes, and ask questions about the program. Your participation is critical in this session.
ACPE #129-000-07-044-L04

Epilepsy and Antiepileptic Drugs: Using Patients to Illustrate New Information
Jim McAuley, Ph.D.
Associate Professor of Pharmacy Practice and Neurology
The Ohio State University
Using several patient scenarios, this presentation will cover new information on the treatment of epilepsy and the use of antiepileptic drugs. Examples include treatment in women of childbearing potential, the elderly, patients with resistant seizures and more. We will also discuss the use of antiepileptic drugs outside of epilepsy and generic substitution in this patient-based presentation.
ACPE #129-000-07-045-L01 

10:30 a.m.
CE Credit per Program: 0.2 CEU

Update on New Drugs 2007
Karen L. Kier, Ph.D., M.Sc., R.Ph.
Professor of Clinical Pharmacy
Director, Drug Information
Ohio Northern University College of Pharmacy
In this annual new drug update, our speaker will review the pharmacology and therapeutics of the medications released in the past year. Indications, mechanisms of action, adverse effects, warnings, drug interactions, and patient counseling information will be included. The practical and immediately applicable information will benefit pharmacists in all practice settings.
ACPE #129-000-07-046-L01

Overview of Poison Control Center Services
Jerry Wiesenhahn, R.Ph., CSPI
Cincinnati Drug and Poison Information Center
Poison control centers are located throughout the country and offer a multitude of services beyond emergency treatment of poisonings. This session will provide a brief history of poison control centers, accreditation of the centers and their staff, as well as educational resources available to the community and health care providers.
ACPE #129-000-07-047-L04

Drug Diversion & Scope of the Problem 2007
John J. Burke
Warren County Ohio, Drug Task Force
President, National Association of Drug Diversion Investigators
Veteran law enforcement professional John Burke will help pharmacists understand the extent of drug diversion and will also give participants an appreciation for the "street value" of certain prescription drugs. He will identify the top prescription and over-the-counter drugs of abuse, discuss the trend of "pharm parties" among teenagers, and describe the impact of the new regulations for sale of pseudoephedrine products.
ACPE #129-000-07-048-L04